Leidos Invests $10M in AI Disease Detection with University of Pittsburgh
Leidos is investing $10 million in collaboration with the University of Pittsburgh to develop AI tools for disease detection and management.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Leidos is investing $10 million in collaboration with the University of Pittsburgh to develop AI tools for disease detection and management.
Caregentic has appointed Russ Johannesson as CEO to lead its AI-driven healthcare platform's expansion, announced in a press release.
DataFirst and TeleRay have announced a partnership to improve virtual care and radiology imaging through AI-powered solutions, enhancing connectivity and diagnostic workflows.
nference and BeiGene have announced a collaboration to enhance research on B-cell cancers using AI technology, focusing on chronic lymphocytic leukemia and small lymphocytic lymphoma.
Biostate AI has partnered with the Accelerated Cure Project to develop AI models for predicting disease progression in multiple sclerosis, leveraging ACP's biorepository data.
Exiger's report reveals significant risks in U.S. healthcare supply chains, with a heavy reliance on China for pharmaceutical ingredients, including antibiotics linked to forced labor.
Assort Health has raised $26 million to expand its AI platform for managing patient phone calls, aiming to improve healthcare access by reducing hold times and scheduling errors.
Baijiayun Group Ltd has announced a strategic partnership with Xinlantian to develop AI-driven rehabilitation programs for autistic children, enhancing personalized care through advanced technology.
Cohere Health has announced the addition of Dr. Paul Johnson, an experienced spine surgeon, to its Medical Advisory Board to enhance its AI-powered clinical intelligence solutions.
Voiant has acquired Voxeleron to enhance its AI-driven ophthalmic image analysis capabilities, aiming to accelerate the development of treatments for eye diseases.
Clario has announced a multi-year collaboration with Amazon Web Services (AWS) to advance its generative AI platform for clinical data analysis, as stated in a press release. This partnership aims to streamline clinical document processing and reduce trial startup times.
ScreenPoint Medical will present its latest advancements in breast AI technology, Transpara, at the 2025 Society of Breast Imaging Symposium. The updated Transpara 2.1 algorithm offers enhanced breast cancer detection capabilities.
Eko Health has launched its AI-powered stethoscope platform in the UK, offering advanced digital auscultation tools to clinicians via EkoHealth.com and Amazon UK.
Well has secured $30 million in funding to expand its AI-powered health engagement system, bringing its total funding to over $150 million.
Subtle Medical has announced a partnership with Strategic Radiology to offer its SubtleELITE Imaging AI Suite to over 2,000 radiologists at exclusive pricing.
hellocare.ai has raised $47 million to enhance its AI-assisted virtual care platform, transforming hospital rooms into smart, connected environments.
Optellum has entered an agreement with Bristol Myers Squibb to enhance early lung cancer diagnosis using AI technology, as announced in a press release.
Breakthrough Genomics has announced a significant advancement in genome interpretation with the launch of the world's first fully-interpreted variant literature database, as stated in a press release.
NEC Laboratories Europe and Data-Driven.AI are collaborating to improve AI-driven medical diagnostics, focusing on early disease detection and preventive health measures.
Illumina and Tempus have announced a collaboration to enhance precision medicine through genomic AI innovation, as stated in a press release. The partnership aims to accelerate the clinical adoption of next-generation sequencing tests.